David W. Howells

Active 1991–2024

65
Papers
27,355
Citations
55
h-index
64
i10-index

Citations

Citations per year for David W. Howells1963: 1 citations1994: 1 citations1995: 1 citations1996: 2 citations1998: 2 citations1999: 8 citations2000: 11 citations2001: 19 citations2002: 23 citations2003: 15 citations2004: 27 citations2005: 35 citations2006: 38 citations2007: 80 citations2008: 88 citations2009: 105 citations2010: 146 citations2011: 112 citations2012: 166 citations2013: 250 citations2014: 323 citations2015: 232 citations2016: 247 citations2017: 245 citations2018: 186 citations2019: 665 citations2020: 716 citations2021: 1,154 citations2022: 996 citations2023: 629 citations2024: 1,249 citations2025: 424 citations2026: 6 citations1964–1993: no citations, so these years are not shown1997: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,288 citing papers, 21.3% of this breakdownChina: 1,169 citing papers, 10.9% of this breakdownUnited Kingdom: 962 citing papers, 9% of this breakdownGermany: 643 citing papers, 6% of this breakdownCanada: 543 citing papers, 5.1% of this breakdownAustralia: 508 citing papers, 4.7% of this breakdownItaly: 330 citing papers, 3.1% of this breakdownNetherlands: 324 citing papers, 3% of this breakdownFrance: 293 citing papers, 2.7% of this breakdownSpain: 262 citing papers, 2.4% of this breakdownBrazil: 245 citing papers, 2.3% of this breakdownSwitzerland: 229 citing papers, 2.1% of this breakdown
0%21.3%Other 27.4%

Fields

  • Medicine41.6%
  • Neuroscience20.4%
  • Biochemistry, Genetics and Molecular Biology16.7%
  • Veterinary4.1%
  • Decision Sciences2.5%
  • Immunology and Microbiology2.3%
  • Other12.4%

Topics

  • Neuroinflammation and Neurodegeneration Mechanisms4.5%
  • Acute Ischemic Stroke Management2.5%
  • Nerve injury and regeneration2.2%
  • Animal testing and alternatives1.8%
  • Neurogenesis and neuroplasticity mechanisms1.6%
  • Neurological Disease Mechanisms and Treatments1.4%
  • Other86%

Coauthors

All papers

Open in search
  1. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research*

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - BMC Veterinary Research 2020 cited by 5,581

  2. Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - PLoS Biology 2020 cited by 2,792

  3. The ARRIVE guidelines 2019: updated guidelines for reporting animal research

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - 2019 cited by 1,053

  4. Reporting animal research: Explanation and Elaboration for the ARRIVE guidelines 2019

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - 2019 cited by 564

  5. Pericytes and Neurovascular Function in the Healthy and Diseased Brain

    Authors: , , , , , - Frontiers in Cellular Neuroscience 2019 cited by 415

  6. Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations

    Authors: , , , , , , - Stroke 2009 cited by 1,318

  7. How to increase value and reduce waste when research priorities are set

    Authors: , , , , , , , , - The Lancet 2014 cited by 1,476

  8. The ARRIVE guidelines 2.0: updated guidelines for reporting animalresearchThe ARRIVE guidelines 2.0: updated guidelines for reporting animalresearch

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - BMJ Open Science 2020 cited by 277

  9. 1,026 Experimental treatments in acute stroke

    Authors: , , , , , - Annals of Neurology 2006 cited by 1,465

  10. Pooling of Animal Experimental Data Reveals Influence of Study Design and Publication Bias

    Authors: , , , - Stroke 2004 cited by 774

  11. Can Animal Models of Disease Reliably Inform Human Studies?

    Authors: , , , , , , - PLoS Medicine 2010 cited by 1,331

  12. Meta-analysis of data from animal studies: A practical guide

    Authors: , , , , , , , , - Journal of Neuroscience Methods 2013 cited by 496

  13. A call for transparent reporting to optimize the predictive value of preclinical research

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Steve Perrin, John D. Porter, Oswald Steward, Ellis F. Unger, Ursula Utz, Shai D. Silberberg - Nature 2012 cited by 1,224

  14. Reduced BDNF mRNA Expression in the Parkinson's Disease Substantia Nigra

    Authors: , , , , , , - Experimental Neurology 2000 cited by 508

  15. Acute Stroke Biomarkers: Are We There Yet?

    Authors: , , , , - Frontiers in Neurology 2021 cited by 126

  16. Circadian Biology and Stroke.

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Stroke 2021 cited by 84

  17. Standardized mean differences cause funnel plot distortion in publication bias assessments

    Authors: , , , , , , , , - eLife 2017 cited by 218

  18. Microglia directly associate with pericytes in the central nervous system

    Authors: , , , , , , , , , , , - Glia 2023 cited by 51

  19. Systematic Reviews and Meta-Analysis of Preclinical Studies: Why Perform Them and How to Appraise Them Critically

    Authors: , , , , - Journal of Cerebral Blood Flow & Metabolism 2014 cited by 263

  20. Publication Bias in Reports of Animal Stroke Studies Leads to Major Overstatement of Efficacy

    Authors: , , , , - PLoS Biology 2010 cited by 595

  21. Evaluation of Excess Significance Bias in Animal Studies of Neurological Diseases

    Authors: , , , , , , , , - PLoS Biology 2013 cited by 299

  22. Changes in the solubility and phosphorylation of α-synuclein over the course of Parkinson’s disease

    Authors: , , , , , , , , , , - Acta Neuropathologica 2011 cited by 132

  23. Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis

    Authors: , , , , - Brain 2007 cited by 496

  24. How can we improve the pre-clinical development of drugs for stroke?

    Authors: , , , - Trends in Neurosciences 2007 cited by 367